Document is current
Any future updates will be listed below
-
Authors
Li, Caie
Ma, Jie
Wang, Qiongying
Ma, Liping
Han, Juncheng
Qi, Yali
Pei, Xiaxia
Yu, Jing
-
Funding
Funding for this research was provided by:
Science and Technology Department of Gansu Province (23JRRA1506)
Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital (CY2024-MS-B11)
National Natural Science Foundation of China (NSFC- 82460086)
- License Information
-
More Information
Article History
Received: 7 December 2024
Accepted: 21 February 2025
First Online: 6 March 2025
Declarations
:
: The authors declare no competing interests.
: The study received approval from the institutional ethics committee.
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the appropriate institutional review board or ethics committee. Informed consent was obtained from all individual participants included in the study. Participants were provided with detailed information regarding the purpose, procedures, potential risks, and benefits of the study. They were assured that their participation was voluntary and that they could withdraw from the study at any time without any consequences.
: All authors consent to the publication of this manuscript in Cardiovascular Drugs and Therapy.
